Virtu Financial LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 22 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q4 2019$22,000
+22.2%
39,938
+133.9%
0.00%
+100.0%
Q3 2019$18,000
-75.3%
17,075
-72.8%
0.00%
-75.0%
Q2 2019$73,000–62,822–0.00%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q4 2019
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders